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Background: Multiple sclerosis (MS) is a disease of the nervous system that has profound 
effects on everyday functioning and quality of life of not only the person who is diagnosed, but 
also her/his family and acquaintances. Despite this, the uncertainties of the actual etiological basis 
of MS make it difficult to reach a conclusive statement about the optimal therapeutic manage-
ment of the disease, which may differ depending on the given case and phase of illness. This 
has led to an interest in potential novel therapeutic avenues, including percutaneous transluminal 
angioplasty (PTA). Yet, evidence in support of PTA in the management of MS is scarce and 
contradictory. The aim of the present study was to provide a preliminary assessment as to whether 
PTA may impact subjective quality of life and cognitive functioning in severe MS. 
Method: Ninety-five MS outpatients were followed-up for 24 months on a scheduled basis 
using the Milan Overall Dementia Assessment and the short-form 36-item scales, and were 
clinically evaluated by an appointed neurologist and psychiatrist. 
Results: At end point (month 24), only a minority of patients were still active in the study 
(n=33 or 34.74%). Among other measures, those who remained in the study until completion 
showed a significantly better Expanded Disability Status Scale and Milan Overall Dementia 
Assessment autonomy profile at study entrance compared to those patients who did not remain 
in the study until completion. Limitations were: a lack of any active control group; small sample 
size; Berkson’s bias; and selection by indication biases.
Conclusion: Given the burden of MS and its high attrition rate, additional studies, including 
bigger samples, active control groups, and Cox’s regression and survival analysis in case of 
randomization, should shed further light on the actual usefulness of PTA for the most severe 
cases of MS.
Keywords: CCSVI, chronic cerebrospinal venous insufficiency, PTA
Introduction
Multiple sclerosis (MS) is a severe, chronic, and often debilitating disease affecting 
the central nervous system (CNS), leading to damage of the myelin sheath resulting in 
a progressive alteration of neuronal transmission. Despite the intense research efforts 
made within the past decades, the etiology and optimal therapeutic intervention for 
MS are far from achieving a satisfactory understanding.1,2 MS symptoms depend 
upon the involvement of multiple central nervous system areas, which accounts for 
intra- and interindividual variability of the clinical pictures and therapeutic outcomes. 
Specifically, besides the motor and sensory impairments, cognitive impairments 
(memory, concentration, judgment, and reasoning skills) significantly affect the critical 
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thinking and judgment abilities as well as the willingness of 
the sufferer to accept his/her own condition, which, in turn, 
significantly affects willingness to seek (additional) medical 
support and/or to adhere to chronic treatment plans, espe-
cially in cases of invasive surgical procedures.3,4 Concerning 
MS etiopathogenesis, self-immunity is undoubtedly a core 
mechanism in the disease.5 Yet, the potential involvement 
of chronic cerebrospinal venous insufficiency (CCSVI) in 
MS has also been identified, albeit by a restricted number of 
clinicians, and represents a matter of vivid debate.6,7 Authors 
advocating a causative relationship between MS and CCSVI 
propose that, at least in some MS subjects at more advanced 
clinical stages of the disease, CCSVI may contribute to a 
reflux and cerebral venous stasis, leading to reduction of 
oxygen levels as well as neuronal and tissue damage that 
are thought to determine the harmful reaction of the immune 
system towards the body.8 Ideally, based on this hypothesis, 
jugular vein percutaneous transluminal angioplasty (PTA) 
for the management of CCSVI9,10 should enhance the psy-
chological functioning and subjective perception of quality 
of life (QoL) in MS patients.
Therefore, the aim of the present study was to assess 
the perception of QoL in MS patients before and after PTA 
intervention within a 24-month follow-up in relation to 
neurocognitive functioning.
Materials and methods
study participants
One hundred and two Italian Caucasian MS patients of 
both sexes aged 18–75 years with an education level of 
12th grade (high school diploma or higher) were referred 
to our outpatient facility by their own clinical neurologists 
(74% from Sardinia, 11% from Emilia-Romagna, 6% from 
Sicily; 9% from elsewhere). Disability due to MS was 
evaluated according to the Expanded Disability Status Scale 
(EDSS) score11 by a clinical neurologist. Patients providing 
a valid informed consent for this study were screened and 
followed-up at the SC Transplant and Vascular Surgery Unit 
of the University of Catania, Italy between July 2011 and 
April 2014 after procedures had been fully explained by 
the reference surgeon and the psychiatrists involved in this 
longitudinal study. The local ethical committee approved 
study procedures in accordance to the Ethical Principles 
for Medical Research Involving Human Subjects indicated 
by the 2004 World Medical Association Declaration of 
Helsinki.12 The cognitive functioning and subjective percep-
tion of QoL by the patients were assessed by means of the 
Milan Overall Dementia Assessment (MODA) – including 
a specific scoring for MS13 – and the short-form 36-item 
(SF-36),14 respectively. A liaison psychiatrist (CDP) with an 
extensive experience with MS patients ruled out any axis II 
or axis I psychiatric diagnosis. Any concomitant medications 
(for any reason) – including recent use (1 month prior) of 
immunosuppressant drugs or illegal substance use, presence 
of any relevant medical comorbidity, or refusal to provide 
a valid informed consent – were considered as exclusion 
criteria.
Neuropsychological functioning  
and Qol assessment
The EDSS steps 1.0–4.5 refer to people with MS who are 
fully ambulatory. EDSS steps 5.0–9.5 indicate impairment 
to ambulation. The EDSS could range from zero (normal 
neurological exam) to ten (dead due to MS).
The MODA includes three sections: the first section 
(score range: 0–35) tests temporal, spatial orientation, and 
personal semantic memory (eg, date and place of birth, 
personal address); the second section (range: 0–15) covers 
the degree of autonomy of the patient; and the third section 
(range: 0–50) examines cognitive abilities (attention, verbal 
intelligence, verbal memory, language, visual–perceptual 
abilities, and constructional apraxia). Each section has its 
own score; the grand score (range: 0–100) is the sum of the 
partial scores adjusted for age and educational level. Higher 
scores on the MODA indicate better functioning.
Both the MODA and the SF-36 (which detects three 
different indices related to the health and psychological–
emotional status through investigation of physical activity, 
physical role, physical pain, global well-being, vitality, social 
activities, emotional role, and mental status) were submitted 
before PTA intervention and 6, 12, and 24 months thereafter. 
Higher scores on the SF-36 also indicate a better level of 
subjective well-being. For additional information about the 
PTA procedure, please refer to Schaller.15
statistical analysis
The Kolmogorov–Smirnov test ascertained normal distri-
bution of data. Parametric tests included χ2, independent 
samples t-test for baseline comparisons among those going 
to complete the study at month 24 versus those dropping 
out earlier (either at month 6 or month 12 for any reasons), 
and one-way repeated measure analysis of variance (using 
the Mauchly’s test to assess the assumption of sphericity). 
Pearson’s R correlation test and binary logistic regression 
regarded only clinically suggestive selected measures. 
Finally, all comparisons were two-tailed.
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Results
Baseline demographic and clinical features
Of the 102 outpatients screened, 95 provided a valid informed 
consent to participate in the study; five patients did not attend 
the baseline appointment, while two patients/their legal 
guardians refused to sign the informed consent. Baseline 
patients included 58 (61.1%) females and 37 (38.9%) males. 
Mean age of the patients at presentation was 44.60±10.48 
(range 20–70) years; patient-declared age at MS diagnosis 
was 30.79±9.33 (range: 10–60) years; mean years lapsed 
since MS diagnosis was 12.84±8.62 (range: 1–40) years; and 
average education level was 11.71±3.21 (range: 5–19) years. 
Mean EDSS score at study entrance was 5.10±2.18 (range 
1–8), indicating a severe MS condition on average.
Dropouts across the study were as follows: at month 6, 
n=11 (11.58%); at month 12, n=34 (35.79%); and at month 
24 (study endpoint), n=17 (17.9%). Cumulative dropouts 
within the study were as much as n=62 (65.26%), or study 
Table 1 Baseline clinical features of study completers versus non-completers at 24-month follow-up
Study subjects  (n=95) Completers 
n=33 (34.74%)
Non-completers 
n=62 (65.26%)
t or χ2  (df ) P-value
Sociodemographics
sex, female/male, n (%) 22 (23%)/11 (11%) 36 (38%)/26 (27%) 0.670 (1) ns
age in years, mean ± sd; (range) 43±10; (20–65) 46±10; (23–70) 1.321 (66) ns
age at Ms diagnosis,  mean ± sd; (range) 31±8; (17–42) 31±10; (10–60) -246 (80) ns
Years lapsed since Ms diagnosis,  mean ± sd; (range) 11±8; (1–34) 14±9; (1–40) 1.478 (93) ns
Years of education, mean ± sd; (range) 12±3; (5–18) 11±3; (5–19) -1.468 (93) ns
Clinical features
eDss score, mean ± sd; (range) 4±2; (1–7) 5±2; (1–8) 2.707 (82) 0.008
MODa total score, mean ± sd; (range) 84±6; (66–100) 87±7; (66–100) 1.484 (93) ns
MODa orientation, mean ± sd; (range) 34±1; (30–35) 35±0; (32–35) 1.306 (38) ns
MODa autonomy, mean ± sd; (range) 14±1; (11–15) 13±2; (7–15) -3.000 (93) 0.003
MODa neuropsychological functioning, mean ± sd; (range) 40±6; (25–50) 42±5; (33–40) 1.843 (93) ns
MODa reversal learning, mean ± sd; (range) 4±1; (2–5) 5±1; (2–5) 1.287 (47) ns
MODa attention, mean ± sd; (range) 9±1; (7–10) 9±1; (5–10) 0.276 (93) ns
MODa verbal intelligence, mean ± sd; (range) 3±2; (0–6) 4±2; (0–6) 1.945 (93) ns
MODa prose memory, mean ± sd; (range) 4±2; (0–8) 4±2; (0–8) 0.987 (93) ns
MODA verbal fluency, mean ± sd; (range) 4±1; (1–5) 4±1; (0–5) 0.006 (93) ns
MODa token test, mean ± sd; (range) 5±0; (3–5) 5±0; (3–5) 1.024 (93) ns
MODA finger agnosia, mean ± sd; (range) 4±1; (0–5) 4±1; (0–5) 0.373 (93) ns
MODa constructional apraxia, mean ± sd; (range) 3±0; (0–3) 3±0; (0–3) 0.495 (93) ns
MODa street completion test, mean ± sd; (range) 2±0; (1–3) 2±0; (1–3) 1.500 (93) ns
sF-36 physical activity, mean ± sd; (range) 48±33; (0–100) 37±33; (0–100) -1.149 (92) ns
sF-36 physical role, mean ± sd; (range) 28±36; (0–100) 30±37; (0–100) -1.430 (92) ns
sF-36 somatic pain, mean ± sd; (range) 66±33; (0–100) 65±33; (0–100) 0.218 (92) ns
sF-36 global health, mean ± sd; (range) 51±25; (5–92) 45±23; (0–97) -1.89 (92) ns
sF-36 vitality, mean ± sd; (range) 52–22; (15–100) 42±23; (0–100) -2.030 (92) ns
sF-36 social activity, mean ± sd; (range) 59–26; (12–100) 58±28; (0–100) -0.250 (92) ns
sF-36 emotional role, mean ± sd; (range) 43±40; (0–100) 50±41; (0–100) 0.781 (92) ns
sF-36 mental health, mean ± sd; (range) 67–22; (12–100) 61–22; (16–96) -1.178 (92) ns
Note: Completers had a slightly, yet statistically significant, better baseline profile: lower EDSS score and higher autonomy functioning according to the MODA.
Abbreviations: EDSS, Expanded Disability Status Scale; MODA, Milan Overall Dementia Assessment; ns, not significant; sd, standard deviation; SF-36, short form-36 item.
completers, n=33 (34.74%). Higher EDSS score at study 
entrance correctly predicted attrition, with a relevant binary 
logistic regression model correctly classifying 21 out of 
33 (69%) of study completers (Exp(B) =0.753; P=0.011). 
Table 1 provides a detailed comparison of baseline demo-
graphic and clinical features between study completers 
(endpoint =24 months) versus non-completers.
Neurocognitive functioning  
and subjective Qol
Selected Pearson’s correlations (P0.005 or P0.001) 
included the following: MODA total score at baseline and 
EDSS score (R=–0.292); months 6–12–24 MODA total 
scores and reference EDSS score, P=ns (not significant); 
and years elapsed since MS diagnosis and EDSS score 
(R=0.288). Neuropsychological functioning assessed with 
MODA correlated with physical activity measured by the 
SF-36 at baseline (R=0.339), month 6 (R=0.275), month 
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12 (R=0.412), and month 24 (R=0.47). Neuropsychological 
functioning also correlated with mental health (as mea-
sured by SF-36) at baseline (R=0.34), month 6 (R=0.233), 
month 12 (R=0.427), and month 24 (R=0.628). Neuropsy-
chological functioning significantly correlated with social 
activity (as measured by SF-36) at month 24 (R=0.455) but 
not at month 6 or 12, as it was for somatic pain perception 
(as measured by SF-36) at month 24, R=0.385, but not at 
baseline, month 6 or 12. Interestingly,  neuropsychological 
functioning assessed with MODA showed a trend of 
increasingly significant correlation coefficients with 
attention and prose memory (MODA’s domains) across 
different times of evaluation (respectively: baseline, 
R=0.360 and R=0.638; month 6, R=0.280 and R=0.620; 
month 12, R=0.422 and R=0.699; month 24, R=0.643 and 
R=ns). One-way repeated measures analysis of variance for 
selected MODA and SF-36 measures have been reported 
in Figures 1–8.
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Figure 1 MODa neuropsychological functioning test trend in patients followed-up 
for 24 months (four observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=30.132, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.673). The results showed 
that MODA neuropsychological functioning was significantly affected by PTA among 
those being followed-up until the fourth (last) observation of the study (study 
completers), F(2.02, 64.57)=28.59, P0.001.
Abbreviations: MODa, Milan Overall Dementia assessment; PTa, percutaneous 
transluminal angioplasty.
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Figure 2 MODa attention test trend in patients followed-up for 24 months (four 
observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=65.017, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.497). The results showed 
that MODA attention was significantly affected by PTA among those being followed-
up until the fourth (last) observation of the study (study completers), F(1.49, 
47.68)=5.30, P=0.015.
Abbreviations: MODa, Milan Overall Dementia assessment; PTa, percutaneous 
transluminal angioplasty.
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Figure 3 MODa prose memory test trend in patients followed-up for 24 months 
(four observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=22.550, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.738). The results showed 
that MODA prose was significantly affected by PTA among those being followed-
up until the fourth (last) observation of the study (study completers), F(2.21, 
70.82)=6.29, P=0.002.
Abbreviations: MODa, Milan Overall Dementia assessment; PTa, percutaneous 
transluminal angioplasty.
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Figure 4 MODa autonomy test trend in patients followed-up for 24 months (four 
observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=92.545, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.576). The results showed 
that MODA autonomy was significantly affected by PTA among those being 
followed-up until the fourth (last) observation of the study (study completers), 
F(1.73, 55.32)=6.29, P=0.029.
Abbreviations: MODa, Milan Overall Dementia assessment; PTa, percutaneous 
transluminal angioplasty.
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Figure 5 sF-36 physical activity assessment trend in patients followed-up for 
24 months (four observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=37.750, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.725). The results showed 
that SF-36 physical activity was significantly affected by PTA among those being 
followed-up until the fourth (last) observation of the study (study completers), 
F(2.17, 69.56)=4.47, P=0.013.
Abbreviations: PTa, percutaneous transluminal angioplasty; sF-36, short-form 
36-item.
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Figure 6 sF-36 somatic pain assessment trend in patients followed-up for 24 months 
(four observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=22.557, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.682). The results showed 
that SF-36 somatic pain was significantly affected by PTA among those being 
followed-up until the fourth (last) observation of the study (study completers), 
F(2.05, 65.52)=5.53, P=0.006.
Abbreviations: PTa, percutaneous transluminal angioplasty; sF-36, short-form 
36-item.
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Figure 8 sF-36 social activity assessment trend in patients followed-up for 
24 months (four observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=27.689, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.704). The results showed 
that SF-36 social activity was significantly affected by PTA among those being 
followed-up until the fourth (last) observation of the study (study completers), 
F(2.11, 67.59)=5.69, P=0.005.
Abbreviations: PTa, percutaneous transluminal angioplasty; sF-36, short-form 
36-item.
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Figure 7 sF-36 mental health assessment trend in patients followed-up for 
24 months (four observations).
Notes: higher scores indicate better outcomes. Mauchly’s test indicated that 
the assumption of sphericity was violated, χ2(5)=25.648, P0.001; therefore, 
greenhouse-geisser corrected tests are reported (ε=0.695). The results showed 
that SF-36 mental health was significantly affected by PTA among those being 
followed-up until the fourth (last) observation of the study (study completers), 
F(2.09, 66.74)=3.59, P=0.031.
Abbreviations: PTa, percutaneous transluminal angioplasty; sF-36, short-form 
36-item.
Discussion
Overview and limitations of the study
To the best of our knowledge, this is the first explorative 
report including a systematic neuropsychological assessment 
of subjective QoL in MS outpatients undergoing PTA across 
a 24-month follow-up. Nonetheless, a number of limitations 
should be accounted for in the interpretation of the present 
preliminary findings.
Specifically, the sample size of the study was relatively 
small. Moreover, the lack of a control group is a major issue 
in this study, making the current results merely indicative; 
yet these results are serve as a prompt for additional stud-
ies, allowing for between-group(s) comparisons (eg, Cox’s 
regression model) or, ideally, a randomized control group on 
active medication(s) to be studied with survival techniques 
and stratification according to baseline EDSS severity score. 
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Also, the inclusion of severe MS cases highlights the chance 
of a recall bias in MS patients, potentially characterized by 
a more pronounced cognitive decline (though the presence 
of caregivers as an anamnestic source should have counter-
balanced this).
The present preliminary findings may suggest a beneficial 
effect of PTA in those severe MS cases being followed-up 
for 24 months. While some measures on the MODA and 
SF-36 tests showed a slight reduction of efficacy by month 12 
to month 24, it should be acknowledged that MS is character-
ized by a chronic degenerative course of the disease itself. 
Therefore, these findings should further solicit a control 
group replication study on the matter. Additional issues may 
also be addressed, such as the possibility of selection bias due 
to the inclusion of more motivated and financially wealthy 
patients who were able to attend all the post-baseline visits, 
even if living far away from our facility (this issue may also 
contribute to an explanation of the high rate of drop-outs 
by month 6).
Apart from the improvement in MODA neuropsycho-
logical functioning, attention, autonomy, and prose memory 
tests, as well as SF-36 physical and social activities, mental 
health, and somatic pain (Figures 1–8), a suggestive finding 
of the present study is that physical disability (according to 
MODA test and the EDSS assessment) inversely correlated 
with cognitive disability (as assessed by MODA). Paradoxi-
cally, from the subjective perspective of the patient, a wors-
ening of the cognitive profile may inversely correlate with 
perceived QoL, possibly due to a worsening of the critical 
judgment skills of the patient towards his/her own motor and 
functional autonomy.
Ultimately, since perceived QoL represents a very sensi-
tive issue in the long-term management of most severe cases 
of MS with CCSVI, the presented preliminary findings should 
encourage more methodologically rigorous replications of 
studies on this topic.
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